ApprovalTrail

Approval · Notice of Compliance 2822 · 1998

VOFENAL: Notice of Compliance 2822

Issued August 4, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2822
Date
August 4, 1998
Company
Alcon Canada Inc.Mississauga, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Other
Therapeutic class
Anti-inflammatory/analgesic agent
Canadian reference product
VOLTAREN OPHTHA (Ciba Vision Gmbh)

Products in this notice

BrandDINStatus today
VOFENAL02238145Cancelled Post Market

Medicinal ingredients